Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris

Condition:   PITYRIASIS RUBRA PILARIS Intervention:   Drug: Cosentyx Sponsor:   Mayo Clinic Not yet recruiting

Source: ClinicalTrials.gov - November 15, 2017 Category: Research Source Type: clinical trials